Christine Ring sold $149K of Nurix Therapeutics, Inc. (NRIX) stock

Christine Ring, Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX), sold 5,787 shares of NRIX stock worth $149K, per an SEC Form 4 filed Sep 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Sep 2, 2026.

NRIX has moved -1.6% since the trade date, from $25.82 to $25.41 (Sep 21, 2026 close).